Related Experiment Video
Updated: Mar 23, 2026
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
31.5K
Gut microbiota composition and relapse risk in pediatric MS: A pilot study
Helen Tremlett1, Douglas W Fadrosh2, Ali A Faruqi2
1University of British Columbia, Vancouver, BC, Canada.
Journal of the Neurological Sciences
|March 23, 2016
Summary
Gut bacteria composition impacts pediatric multiple sclerosis (MS) relapse risk. Depletion of Fusobacteria at baseline is linked to a higher risk of relapse in children with relapsing-remitting MS.
Area of Science:
- Microbiology
- Neurology
- Immunology
Background:
- Pediatric multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Gut microbiota composition is increasingly recognized as a potential factor influencing MS pathogenesis and progression.
- Understanding the gut microbiome's role in pediatric MS may reveal novel therapeutic targets.
Purpose of the Study:
- To investigate the association between baseline gut microbiota profiles and the risk of relapse in pediatric patients with relapsing-remitting MS.
- To identify specific bacterial taxa that predict future disease activity.
Main Methods:
- 16S rRNA gene sequencing was used to analyze the gut microbiota composition from stool samples of 17 pediatric MS cases.
- Kaplan-Meier survival analysis was employed to assess the time to relapse.
- Statistical analyses, including log-rank tests and covariate-adjusted Cox regression, were performed to determine associations between microbial taxa and relapse risk.
Main Results:
- 25% of pediatric MS patients experienced a relapse within approximately 166 days.
- Shorter time to relapse was significantly associated with depletion of Fusobacteria (p=0.001), expansion of Firmicutes (p=0.003), and presence of Archaea Euryarchaeota (p=0.037).
- After adjusting for age and immunomodulatory drug use, the absence of Fusobacteria remained a significant predictor of relapse risk (HR=3.2, p=0.024).
Conclusions:
- Baseline gut microbiota composition, particularly the absence of Fusobacteria, is associated with an increased risk of relapse in pediatric relapsing-remitting MS.
- These findings suggest that gut bacteria may play a role in MS disease activity in children.
- Further research into targeting the gut microbiome could offer new strategies for managing pediatric MS.
Keywords:
16S rRNACox regressionGut microbiotaKaplan-MeierPediatric multiple sclerosisRelapse riskSurvival analysesMore Related Videos
Related Concept Videos
01:30Development of Human Microbiota
11
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
11
01:22Gut-Brain Axis
31
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
31
01:22Introduction to the Human Microbiota
29
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
29
01:27Microbiota of the Stomach and Small Intestine
8
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
8
01:28Development of the Oral Microbiota
10
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
10
01:18Functions of the Gut Microbiota
5
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
5